Comments
Loading...

Telix Pharmaceuticals Analyst Ratings

TLXNASDAQ
Logo brought to you by Benzinga Data
$17.30
-0.30-1.70%
At close: -
$17.60
0.301.73%
After Hours: 7:12 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$22.00
Lowest Price Target1
$22.00
Consensus Price Target1
$22.00

Telix Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:TLX | Benzinga

Telix Pharmaceuticals Ltd has a consensus price target of $22 based on the ratings of 1 analysts. The high is $22 issued by UBS on January 27, 2025. The low is $22 issued by UBS on January 27, 2025. The 2 most-recent analyst ratings were released by UBS on January 27, 2025 and November 15, 2024, respectively. With an average price target of $21.5 between UBS, there's an implied 22.16% upside for Telix Pharmaceuticals Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Nov 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS

1calculated from analyst ratings

Analyst Ratings for Telix Pharmaceuticals

Buy NowGet Alert
01/27/2025Buy Now25%UBS
Laura Sutcliffe
$21 → $22MaintainsBuyGet Alert
11/15/2024Buy Now19.32%UBS
Laura Sutcliffe
→ $21Initiates → BuyGet Alert

FAQ

Q

What is the target price for Telix Pharmaceuticals (TLX) stock?

A

The latest price target for Telix Pharmaceuticals (NASDAQ:TLX) was reported by UBS on January 27, 2025. The analyst firm set a price target for $22.00 expecting TLX to rise to within 12 months (a possible 25.00% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Telix Pharmaceuticals (TLX)?

A

The latest analyst rating for Telix Pharmaceuticals (NASDAQ:TLX) was provided by UBS, and Telix Pharmaceuticals maintained their buy rating.

Q

When was the last upgrade for Telix Pharmaceuticals (TLX)?

A

There is no last upgrade for Telix Pharmaceuticals

Q

When was the last downgrade for Telix Pharmaceuticals (TLX)?

A

There is no last downgrade for Telix Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Telix Pharmaceuticals (TLX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Telix Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Telix Pharmaceuticals was filed on January 27, 2025 so you should expect the next rating to be made available sometime around January 27, 2026.

Q

Is the Analyst Rating Telix Pharmaceuticals (TLX) correct?

A

While ratings are subjective and will change, the latest Telix Pharmaceuticals (TLX) rating was a maintained with a price target of $21.00 to $22.00. The current price Telix Pharmaceuticals (TLX) is trading at is $17.60, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch